BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30589850)

  • 1. Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
    Nørgaard CH; Søgaard NB; Biccler JL; Pilgaard L; Eskesen MH; Kjartansdottir TH; Bøgsted M; El-Galaly TC
    PLoS One; 2018; 13(12):e0208180. PubMed ID: 30589850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
    Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
    Brieghel C; Galle V; Agius R; da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
    Eur J Haematol; 2022 May; 108(5):369-378. PubMed ID: 35030282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher percentage of in vitro apoptotic cells at time of diagnosis in patients with chronic lymphocytic leukemia indicate earlier treatment requirement: ten years follow up.
    Kravić-Stevović T; Bogdanović A; Bumbasirević V
    Srp Arh Celok Lek; 2014; 142(1-2):48-53. PubMed ID: 24684031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect
    Flowers CR; Nabhan C; Kay NE; Mato A; Lamanna N; Farber CM; Davids MS; Kiselev P; Swern AS; Sullivan K; Flick ED; Sharman JP
    Leuk Lymphoma; 2018 Oct; 59(10):2327-2335. PubMed ID: 29415595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention in asymptomatic chronic lymphocytic leukemia.
    Muchtar E; Kay NE; Parikh SA
    Clin Adv Hematol Oncol; 2021 Feb; 19(2):92-103. PubMed ID: 33596191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
    Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
    Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
    Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
    Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.
    Apelgren P; Hasselblom S; Werlenius O; Nilsson-Ehle H; Andersson PO;
    Leuk Lymphoma; 2006 Dec; 47(12):2505-16. PubMed ID: 17169795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care management of early stage chronic lymphocytic leukaemia is safe and effective.
    Parry HM; Damery S; Mudondo NP; Hazlewood P; McSkeane T; Aung S; Murray J; Pratt G; Moss P; Milligan DW
    QJM; 2015 Oct; 108(10):789-94. PubMed ID: 25638788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
    Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
    Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
    Oliveira AC; de la Banda E; Domingo-Domenech E; Encuentra M; Mercadal S; Domingo A; Alonso E; Espinet B; Grau J; De Sevilla AF; Gonzalez-Barca E
    Leuk Lymphoma; 2011 Mar; 52(3):429-35. PubMed ID: 21323523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
    Molica S; Mauro FR; Callea V; Gentile M; Giannarelli D; Lopez M; Lauria F; Rotoli B; Montanaro M; Cortelezzi A; Liso V; Mandelli F; Foa R;
    Leuk Lymphoma; 2005 Apr; 46(4):553-60. PubMed ID: 16032778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.
    Vicente EP; Cuellar-García C; Martinez M; Soler A; Mora A; Bosch R; Brunet S; Briones J; García I; Esquirol A; Granell M; Saavedra S; Nomdedeu J; Sierra J; Martino R; Moreno C
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):737-742. PubMed ID: 30017595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia: a retrospective study of 122 cases.
    Erlanson M; Osterman B; Jonsson H; Lenner P
    Eur J Haematol; 1994 Feb; 52(2):108-14. PubMed ID: 8119380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.